This article is more than 5 years old. Information may no longer be current.

Fresenius wins patent battle with Baxter over touch screens on hemodialysis machines

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Fresenius Medical Care AG won a U.S. appeals court ruling July 3 that ended a patent-infringement claim brought by Baxter International Inc. over touch screens on hemodialysis machines.

The U.S. Court of Appeals for the Federal Circuit ruled that there is no longer any basis for Baxter’s claim because the U.S. Patent and Trademark Office had canceled the Baxter patent after a review while the civil suit was still pending, according to Bloomberg.